nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—bone marrow—stomach cancer	0.01	0.113	CbGeAlD
Vigabatrin—SLC36A1—pancreas—stomach cancer	0.00999	0.112	CbGeAlD
Vigabatrin—ABAT—pancreas—stomach cancer	0.00993	0.112	CbGeAlD
Vigabatrin—SLC36A1—digestive system—stomach cancer	0.00854	0.0959	CbGeAlD
Vigabatrin—SLC36A1—bone marrow—stomach cancer	0.00787	0.0884	CbGeAlD
Vigabatrin—SLC36A1—endocrine gland—stomach cancer	0.00705	0.0792	CbGeAlD
Vigabatrin—ABAT—endocrine gland—stomach cancer	0.00701	0.0787	CbGeAlD
Vigabatrin—SLC36A1—liver—stomach cancer	0.00636	0.0714	CbGeAlD
Vigabatrin—ABAT—liver—stomach cancer	0.00632	0.071	CbGeAlD
Vigabatrin—GABBR1—lymph node—stomach cancer	0.00621	0.0697	CbGeAlD
Vigabatrin—SLC36A1—lymph node—stomach cancer	0.00488	0.0548	CbGeAlD
Vigabatrin—ABAT—lymph node—stomach cancer	0.00485	0.0544	CbGeAlD
Vigabatrin—ABAT—GABA synthesis, release, reuptake and degradation—HSPA8—stomach cancer	0.00317	0.107	CbGpPWpGaD
Vigabatrin—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC1A2—stomach cancer	0.00231	0.0781	CbGpPWpGaD
Vigabatrin—ABAT—Neurotransmitter Release Cycle—HSPA8—stomach cancer	0.00168	0.0568	CbGpPWpGaD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—stomach cancer	0.00136	0.046	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—SLC1A2—stomach cancer	0.000808	0.0273	CbGpPWpGaD
Vigabatrin—Confusional state—Docetaxel—stomach cancer	0.000779	0.000884	CcSEcCtD
Vigabatrin—Anxiety—Capecitabine—stomach cancer	0.000778	0.000883	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000775	0.00088	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Epirubicin—stomach cancer	0.000773	0.000877	CcSEcCtD
Vigabatrin—Oedema—Docetaxel—stomach cancer	0.000773	0.000877	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—stomach cancer	0.000772	0.000876	CcSEcCtD
Vigabatrin—Discomfort—Capecitabine—stomach cancer	0.000771	0.000875	CcSEcCtD
Vigabatrin—Infection—Docetaxel—stomach cancer	0.000768	0.000871	CcSEcCtD
Vigabatrin—Sinusitis—Epirubicin—stomach cancer	0.000767	0.00087	CcSEcCtD
Vigabatrin—Diarrhoea—Irinotecan—stomach cancer	0.000765	0.000868	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—stomach cancer	0.000761	0.000863	CcSEcCtD
Vigabatrin—Nervous system disorder—Docetaxel—stomach cancer	0.000758	0.00086	CcSEcCtD
Vigabatrin—Pruritus—Fluorouracil—stomach cancer	0.000758	0.00086	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—stomach cancer	0.000756	0.000858	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—stomach cancer	0.000756	0.000858	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—stomach cancer	0.000756	0.000858	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—stomach cancer	0.000756	0.000857	CcSEcCtD
Vigabatrin—Confusional state—Capecitabine—stomach cancer	0.000755	0.000856	CcSEcCtD
Vigabatrin—Skin disorder—Docetaxel—stomach cancer	0.000751	0.000852	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00075	0.000851	CcSEcCtD
Vigabatrin—Oedema—Capecitabine—stomach cancer	0.000748	0.000849	CcSEcCtD
Vigabatrin—Infection—Capecitabine—stomach cancer	0.000744	0.000844	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—stomach cancer	0.000741	0.000841	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000741	0.000841	CcSEcCtD
Vigabatrin—Dizziness—Irinotecan—stomach cancer	0.000739	0.000839	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—stomach cancer	0.000735	0.000834	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—stomach cancer	0.000735	0.000834	CcSEcCtD
Vigabatrin—Nervous system disorder—Capecitabine—stomach cancer	0.000734	0.000833	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—stomach cancer	0.000733	0.000832	CcSEcCtD
Vigabatrin—Diarrhoea—Fluorouracil—stomach cancer	0.000733	0.000831	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—stomach cancer	0.000731	0.00083	CcSEcCtD
Vigabatrin—Hypoaesthesia—Epirubicin—stomach cancer	0.00073	0.000828	CcSEcCtD
Vigabatrin—Skin disorder—Capecitabine—stomach cancer	0.000727	0.000825	CcSEcCtD
Vigabatrin—Oedema peripheral—Epirubicin—stomach cancer	0.000723	0.00082	CcSEcCtD
Vigabatrin—Connective tissue disorder—Epirubicin—stomach cancer	0.000721	0.000818	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000715	0.000812	CcSEcCtD
Vigabatrin—Vomiting—Irinotecan—stomach cancer	0.000711	0.000807	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000711	0.024	CbGpPWpGaD
Vigabatrin—Sinusitis—Doxorubicin—stomach cancer	0.00071	0.000805	CcSEcCtD
Vigabatrin—Dizziness—Fluorouracil—stomach cancer	0.000708	0.000804	CcSEcCtD
Vigabatrin—Visual impairment—Epirubicin—stomach cancer	0.000707	0.000802	CcSEcCtD
Vigabatrin—Rash—Irinotecan—stomach cancer	0.000705	0.0008	CcSEcCtD
Vigabatrin—Dermatitis—Irinotecan—stomach cancer	0.000704	0.000799	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000704	0.000799	CcSEcCtD
Vigabatrin—Headache—Irinotecan—stomach cancer	0.000701	0.000795	CcSEcCtD
Vigabatrin—Insomnia—Docetaxel—stomach cancer	0.000699	0.000793	CcSEcCtD
Vigabatrin—Paraesthesia—Docetaxel—stomach cancer	0.000694	0.000788	CcSEcCtD
Vigabatrin—Erythema multiforme—Epirubicin—stomach cancer	0.000694	0.000787	CcSEcCtD
Vigabatrin—Somnolence—Docetaxel—stomach cancer	0.000687	0.00078	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—stomach cancer	0.000687	0.00078	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—SLC1A2—stomach cancer	0.000687	0.0232	CbGpPWpGaD
Vigabatrin—Eye disorder—Epirubicin—stomach cancer	0.000686	0.000778	CcSEcCtD
Vigabatrin—Tinnitus—Epirubicin—stomach cancer	0.000684	0.000776	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—stomach cancer	0.000683	0.000775	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000682	0.000774	CcSEcCtD
Vigabatrin—Vomiting—Fluorouracil—stomach cancer	0.000681	0.000773	CcSEcCtD
Vigabatrin—Dyspepsia—Docetaxel—stomach cancer	0.00068	0.000772	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—HRH4—stomach cancer	0.000677	0.0229	CbGpPWpGaD
Vigabatrin—Insomnia—Capecitabine—stomach cancer	0.000677	0.000768	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—stomach cancer	0.000676	0.000767	CcSEcCtD
Vigabatrin—Rash—Fluorouracil—stomach cancer	0.000675	0.000766	CcSEcCtD
Vigabatrin—Dermatitis—Fluorouracil—stomach cancer	0.000675	0.000765	CcSEcCtD
Vigabatrin—Paraesthesia—Capecitabine—stomach cancer	0.000672	0.000763	CcSEcCtD
Vigabatrin—Decreased appetite—Docetaxel—stomach cancer	0.000672	0.000762	CcSEcCtD
Vigabatrin—Headache—Fluorouracil—stomach cancer	0.000671	0.000761	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—stomach cancer	0.000669	0.000759	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000667	0.000757	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000667	0.000757	CcSEcCtD
Vigabatrin—Fatigue—Docetaxel—stomach cancer	0.000666	0.000756	CcSEcCtD
Vigabatrin—Nausea—Irinotecan—stomach cancer	0.000664	0.000754	CcSEcCtD
Vigabatrin—Pain—Docetaxel—stomach cancer	0.000661	0.00075	CcSEcCtD
Vigabatrin—Constipation—Docetaxel—stomach cancer	0.000661	0.00075	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—stomach cancer	0.00066	0.000749	CcSEcCtD
Vigabatrin—Dyspepsia—Capecitabine—stomach cancer	0.000659	0.000747	CcSEcCtD
Vigabatrin—Visual impairment—Doxorubicin—stomach cancer	0.000654	0.000742	CcSEcCtD
Vigabatrin—Decreased appetite—Capecitabine—stomach cancer	0.000651	0.000738	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000646	0.000733	CcSEcCtD
Vigabatrin—Fatigue—Capecitabine—stomach cancer	0.000645	0.000732	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—stomach cancer	0.000643	0.00073	CcSEcCtD
Vigabatrin—Mental disorder—Epirubicin—stomach cancer	0.000643	0.000729	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—stomach cancer	0.000642	0.000728	CcSEcCtD
Vigabatrin—Constipation—Capecitabine—stomach cancer	0.00064	0.000726	CcSEcCtD
Vigabatrin—Pain—Capecitabine—stomach cancer	0.00064	0.000726	CcSEcCtD
Vigabatrin—Malnutrition—Epirubicin—stomach cancer	0.000639	0.000725	CcSEcCtD
Vigabatrin—Feeling abnormal—Docetaxel—stomach cancer	0.000637	0.000723	CcSEcCtD
Vigabatrin—Nausea—Fluorouracil—stomach cancer	0.000636	0.000722	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—stomach cancer	0.000635	0.00072	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—stomach cancer	0.000633	0.000719	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—stomach cancer	0.000633	0.000718	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000632	0.000717	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—stomach cancer	0.000631	0.000716	CcSEcCtD
Vigabatrin—Tension—Epirubicin—stomach cancer	0.000627	0.000711	CcSEcCtD
Vigabatrin—Nervousness—Epirubicin—stomach cancer	0.00062	0.000704	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—SLC1A2—stomach cancer	0.000619	0.0209	CbGpPWpGaD
Vigabatrin—Back pain—Epirubicin—stomach cancer	0.000618	0.000701	CcSEcCtD
Vigabatrin—Feeling abnormal—Capecitabine—stomach cancer	0.000617	0.0007	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—stomach cancer	0.000616	0.000698	CcSEcCtD
Vigabatrin—Muscle spasms—Epirubicin—stomach cancer	0.000614	0.000697	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—stomach cancer	0.000613	0.000696	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000612	0.000694	CcSEcCtD
Vigabatrin—Abdominal pain—Docetaxel—stomach cancer	0.000611	0.000693	CcSEcCtD
Vigabatrin—Body temperature increased—Docetaxel—stomach cancer	0.000611	0.000693	CcSEcCtD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000609	0.0206	CbGpPWpGaD
Vigabatrin—Vision blurred—Epirubicin—stomach cancer	0.000602	0.000683	CcSEcCtD
Vigabatrin—Cough—Methotrexate—stomach cancer	0.000596	0.000676	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—stomach cancer	0.000595	0.000675	CcSEcCtD
Vigabatrin—Urticaria—Capecitabine—stomach cancer	0.000595	0.000675	CcSEcCtD
Vigabatrin—Ill-defined disorder—Epirubicin—stomach cancer	0.000593	0.000673	CcSEcCtD
Vigabatrin—Body temperature increased—Capecitabine—stomach cancer	0.000592	0.000671	CcSEcCtD
Vigabatrin—Abdominal pain—Capecitabine—stomach cancer	0.000592	0.000671	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—stomach cancer	0.000591	0.000671	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—stomach cancer	0.000591	0.000671	CcSEcCtD
Vigabatrin—Anaemia—Epirubicin—stomach cancer	0.00059	0.00067	CcSEcCtD
Vigabatrin—Agitation—Epirubicin—stomach cancer	0.000587	0.000666	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—stomach cancer	0.000581	0.000659	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—stomach cancer	0.000581	0.000659	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—stomach cancer	0.000581	0.000659	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—stomach cancer	0.00058	0.000658	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000577	0.000655	CcSEcCtD
Vigabatrin—Malaise—Epirubicin—stomach cancer	0.000576	0.000654	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—stomach cancer	0.000574	0.000652	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—stomach cancer	0.000574	0.000651	CcSEcCtD
Vigabatrin—Vertigo—Epirubicin—stomach cancer	0.000574	0.000651	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—stomach cancer	0.000572	0.000649	CcSEcCtD
Vigabatrin—Hypersensitivity—Docetaxel—stomach cancer	0.00057	0.000646	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—stomach cancer	0.000568	0.000645	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—KISS1R—stomach cancer	0.000567	0.0191	CbGpPWpGaD
Vigabatrin—Confusional state—Methotrexate—stomach cancer	0.000562	0.000637	CcSEcCtD
Vigabatrin—Cough—Epirubicin—stomach cancer	0.000557	0.000633	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—stomach cancer	0.000557	0.000632	CcSEcCtD
Vigabatrin—Asthenia—Docetaxel—stomach cancer	0.000555	0.000629	CcSEcCtD
Vigabatrin—Convulsion—Epirubicin—stomach cancer	0.000554	0.000628	CcSEcCtD
Vigabatrin—Infection—Methotrexate—stomach cancer	0.000554	0.000628	CcSEcCtD
Vigabatrin—Hypersensitivity—Capecitabine—stomach cancer	0.000551	0.000626	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—stomach cancer	0.000548	0.000622	CcSEcCtD
Vigabatrin—Pruritus—Docetaxel—stomach cancer	0.000547	0.000621	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—stomach cancer	0.000546	0.00062	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—stomach cancer	0.000546	0.00062	CcSEcCtD
Vigabatrin—Arthralgia—Epirubicin—stomach cancer	0.000544	0.000617	CcSEcCtD
Vigabatrin—Chest pain—Epirubicin—stomach cancer	0.000544	0.000617	CcSEcCtD
Vigabatrin—Myalgia—Epirubicin—stomach cancer	0.000544	0.000617	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—stomach cancer	0.000543	0.000616	CcSEcCtD
Vigabatrin—Anxiety—Epirubicin—stomach cancer	0.000542	0.000615	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—stomach cancer	0.000541	0.000614	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00054	0.000613	CcSEcCtD
Vigabatrin—Discomfort—Epirubicin—stomach cancer	0.000537	0.00061	CcSEcCtD
Vigabatrin—Asthenia—Capecitabine—stomach cancer	0.000537	0.000609	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—stomach cancer	0.000533	0.000605	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—stomach cancer	0.000531	0.000603	CcSEcCtD
Vigabatrin—Pruritus—Capecitabine—stomach cancer	0.00053	0.000601	CcSEcCtD
Vigabatrin—Diarrhoea—Docetaxel—stomach cancer	0.000529	0.0006	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—SLC1A2—stomach cancer	0.000526	0.0178	CbGpPWpGaD
Vigabatrin—Confusional state—Epirubicin—stomach cancer	0.000526	0.000596	CcSEcCtD
Vigabatrin—Oedema—Epirubicin—stomach cancer	0.000521	0.000592	CcSEcCtD
Vigabatrin—Infection—Epirubicin—stomach cancer	0.000518	0.000588	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—stomach cancer	0.000516	0.000585	CcSEcCtD
Vigabatrin—Convulsion—Doxorubicin—stomach cancer	0.000512	0.000581	CcSEcCtD
Vigabatrin—Diarrhoea—Capecitabine—stomach cancer	0.000512	0.000581	CcSEcCtD
Vigabatrin—Nervous system disorder—Epirubicin—stomach cancer	0.000511	0.00058	CcSEcCtD
Vigabatrin—Dizziness—Docetaxel—stomach cancer	0.000511	0.00058	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000508	0.000576	CcSEcCtD
Vigabatrin—Skin disorder—Epirubicin—stomach cancer	0.000506	0.000575	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—stomach cancer	0.000504	0.000572	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—stomach cancer	0.000503	0.000571	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—stomach cancer	0.000503	0.000571	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—stomach cancer	0.000503	0.000571	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—stomach cancer	0.000502	0.000569	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—stomach cancer	0.0005	0.000568	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.0005	0.000567	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—stomach cancer	0.000497	0.000564	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—stomach cancer	0.000495	0.000562	CcSEcCtD
Vigabatrin—Dizziness—Capecitabine—stomach cancer	0.000495	0.000562	CcSEcCtD
Vigabatrin—Vomiting—Docetaxel—stomach cancer	0.000491	0.000558	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—stomach cancer	0.00049	0.000556	CcSEcCtD
Vigabatrin—Rash—Docetaxel—stomach cancer	0.000487	0.000553	CcSEcCtD
Vigabatrin—Dermatitis—Docetaxel—stomach cancer	0.000487	0.000552	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—stomach cancer	0.000486	0.000552	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—stomach cancer	0.000484	0.00055	CcSEcCtD
Vigabatrin—Headache—Docetaxel—stomach cancer	0.000484	0.000549	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.000483	0.0163	CbGpPWpGaD
Vigabatrin—Oedema—Doxorubicin—stomach cancer	0.000482	0.000547	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000481	0.000546	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—stomach cancer	0.00048	0.000545	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—stomach cancer	0.000479	0.000544	CcSEcCtD
Vigabatrin—Pain—Methotrexate—stomach cancer	0.000476	0.000541	CcSEcCtD
Vigabatrin—Vomiting—Capecitabine—stomach cancer	0.000476	0.00054	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000475	0.000539	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—stomach cancer	0.000473	0.000537	CcSEcCtD
Vigabatrin—Rash—Capecitabine—stomach cancer	0.000472	0.000535	CcSEcCtD
Vigabatrin—Insomnia—Epirubicin—stomach cancer	0.000472	0.000535	CcSEcCtD
Vigabatrin—Dermatitis—Capecitabine—stomach cancer	0.000471	0.000535	CcSEcCtD
Vigabatrin—Headache—Capecitabine—stomach cancer	0.000469	0.000532	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—stomach cancer	0.000469	0.000532	CcSEcCtD
Vigabatrin—Paraesthesia—Epirubicin—stomach cancer	0.000468	0.000531	CcSEcCtD
Vigabatrin—Somnolence—Epirubicin—stomach cancer	0.000464	0.000526	CcSEcCtD
Vigabatrin—Nausea—Docetaxel—stomach cancer	0.000459	0.000521	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—stomach cancer	0.000459	0.000521	CcSEcCtD
Vigabatrin—Dyspepsia—Epirubicin—stomach cancer	0.000459	0.000521	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000456	0.000517	CcSEcCtD
Vigabatrin—Decreased appetite—Epirubicin—stomach cancer	0.000453	0.000514	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00045	0.000511	CcSEcCtD
Vigabatrin—Fatigue—Epirubicin—stomach cancer	0.00045	0.00051	CcSEcCtD
Vigabatrin—Constipation—Epirubicin—stomach cancer	0.000446	0.000506	CcSEcCtD
Vigabatrin—Pain—Epirubicin—stomach cancer	0.000446	0.000506	CcSEcCtD
Vigabatrin—Nausea—Capecitabine—stomach cancer	0.000445	0.000504	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—stomach cancer	0.000443	0.000502	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—stomach cancer	0.00044	0.0005	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—stomach cancer	0.00044	0.0005	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00044	0.000499	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—stomach cancer	0.000436	0.000495	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—stomach cancer	0.000433	0.000492	CcSEcCtD
Vigabatrin—Feeling abnormal—Epirubicin—stomach cancer	0.00043	0.000487	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—stomach cancer	0.000429	0.000487	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000426	0.000484	CcSEcCtD
Vigabatrin—Dyspepsia—Doxorubicin—stomach cancer	0.000425	0.000482	CcSEcCtD
Vigabatrin—Decreased appetite—Doxorubicin—stomach cancer	0.000419	0.000476	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000417	0.000473	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—stomach cancer	0.000416	0.000472	CcSEcCtD
Vigabatrin—Urticaria—Epirubicin—stomach cancer	0.000414	0.00047	CcSEcCtD
Vigabatrin—Pain—Doxorubicin—stomach cancer	0.000413	0.000468	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—stomach cancer	0.000413	0.000468	CcSEcCtD
Vigabatrin—Abdominal pain—Epirubicin—stomach cancer	0.000412	0.000468	CcSEcCtD
Vigabatrin—Body temperature increased—Epirubicin—stomach cancer	0.000412	0.000468	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—stomach cancer	0.00041	0.000466	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.00041	0.0139	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HRH4—stomach cancer	0.00041	0.0138	CbGpPWpGaD
Vigabatrin—Asthenia—Methotrexate—stomach cancer	0.0004	0.000454	CcSEcCtD
Vigabatrin—Feeling abnormal—Doxorubicin—stomach cancer	0.000398	0.000451	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000394	0.000448	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—stomach cancer	0.000394	0.000447	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—AGTR2—stomach cancer	0.000393	0.0133	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Epirubicin—stomach cancer	0.000384	0.000436	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—stomach cancer	0.000383	0.000435	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—stomach cancer	0.000381	0.000433	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—stomach cancer	0.000381	0.000433	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—stomach cancer	0.000381	0.000433	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—HTR1A—stomach cancer	0.000379	0.0128	CbGpPWpGaD
Vigabatrin—Asthenia—Epirubicin—stomach cancer	0.000374	0.000424	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—HSPA8—stomach cancer	0.00037	0.0125	CbGpPWpGaD
Vigabatrin—Pruritus—Epirubicin—stomach cancer	0.000369	0.000419	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—stomach cancer	0.000368	0.000418	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—ANXA1—stomach cancer	0.000366	0.0123	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—KISS1—stomach cancer	0.000366	0.0123	CbGpPWpGaD
Vigabatrin—Diarrhoea—Epirubicin—stomach cancer	0.000357	0.000405	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—stomach cancer	0.000355	0.000403	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—stomach cancer	0.000354	0.000402	CcSEcCtD
Vigabatrin—Rash—Methotrexate—stomach cancer	0.000351	0.000399	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—stomach cancer	0.000351	0.000398	CcSEcCtD
Vigabatrin—Headache—Methotrexate—stomach cancer	0.000349	0.000396	CcSEcCtD
Vigabatrin—Asthenia—Doxorubicin—stomach cancer	0.000346	0.000393	CcSEcCtD
Vigabatrin—Dizziness—Epirubicin—stomach cancer	0.000345	0.000391	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—stomach cancer	0.000341	0.000387	CcSEcCtD
Vigabatrin—Vomiting—Epirubicin—stomach cancer	0.000332	0.000376	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—stomach cancer	0.000331	0.000375	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—stomach cancer	0.00033	0.000375	CcSEcCtD
Vigabatrin—Rash—Epirubicin—stomach cancer	0.000329	0.000373	CcSEcCtD
Vigabatrin—Dermatitis—Epirubicin—stomach cancer	0.000328	0.000373	CcSEcCtD
Vigabatrin—Headache—Epirubicin—stomach cancer	0.000327	0.000371	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—KISS1R—stomach cancer	0.000321	0.0108	CbGpPWpGaD
Vigabatrin—Dizziness—Doxorubicin—stomach cancer	0.000319	0.000362	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—HSPA8—stomach cancer	0.000314	0.0106	CbGpPWpGaD
Vigabatrin—Nausea—Epirubicin—stomach cancer	0.00031	0.000351	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000309	0.0104	CbGpPWpGaD
Vigabatrin—Vomiting—Doxorubicin—stomach cancer	0.000307	0.000348	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—stomach cancer	0.000304	0.000345	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—stomach cancer	0.000304	0.000345	CcSEcCtD
Vigabatrin—Headache—Doxorubicin—stomach cancer	0.000302	0.000343	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	0.000298	0.0101	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KISS1R—stomach cancer	0.000291	0.00983	CbGpPWpGaD
Vigabatrin—Nausea—Doxorubicin—stomach cancer	0.000287	0.000325	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000263	0.00889	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AGTR2—stomach cancer	0.000238	0.00804	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—F2R—stomach cancer	0.000236	0.00795	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HRH4—stomach cancer	0.000232	0.00782	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—HTR1A—stomach cancer	0.000229	0.00774	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000224	0.00756	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ANXA1—stomach cancer	0.000221	0.00748	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRB1—stomach cancer	0.000215	0.00724	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRH4—stomach cancer	0.00021	0.0071	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—KISS1—stomach cancer	0.000207	0.00697	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—PRKCB—stomach cancer	0.000202	0.00681	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KISS1—stomach cancer	0.000188	0.00633	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GAST—stomach cancer	0.000178	0.006	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RGS2—stomach cancer	0.000178	0.006	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ADRB2—stomach cancer	0.000174	0.00587	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KISS1R—stomach cancer	0.000172	0.00581	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GLI3—stomach cancer	0.000172	0.00581	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—PRKCB—stomach cancer	0.000172	0.00579	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000165	0.00556	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RBP1—stomach cancer	0.000164	0.00554	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RGS2—stomach cancer	0.000161	0.00545	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GAST—stomach cancer	0.000161	0.00545	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000153	0.00518	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000139	0.00471	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL8—stomach cancer	0.000139	0.00468	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000136	0.00458	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AGTR2—stomach cancer	0.000135	0.00454	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—WWOX—stomach cancer	0.000134	0.00451	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—F2R—stomach cancer	0.000133	0.00449	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—HTR1A—stomach cancer	0.00013	0.00437	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ANXA1—stomach cancer	0.000125	0.00423	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—WIF1—stomach cancer	0.000124	0.0042	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRH4—stomach cancer	0.000124	0.0042	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000123	0.00416	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGTR2—stomach cancer	0.000122	0.00413	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB1—stomach cancer	0.000121	0.00409	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—F2R—stomach cancer	0.000121	0.00408	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HTR1A—stomach cancer	0.000118	0.00397	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000115	0.00389	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKAB1—stomach cancer	0.000115	0.00387	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ANXA1—stomach cancer	0.000114	0.00384	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KISS1—stomach cancer	0.000111	0.00374	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RNF43—stomach cancer	0.000111	0.00374	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB1—stomach cancer	0.00011	0.00372	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000109	0.00367	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000106	0.00357	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—MAPK1—stomach cancer	0.000104	0.00351	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FST—stomach cancer	9.88e-05	0.00333	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADRB2—stomach cancer	9.82e-05	0.00332	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HBEGF—stomach cancer	9.66e-05	0.00326	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GAST—stomach cancer	9.53e-05	0.00322	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RGS2—stomach cancer	9.53e-05	0.00322	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—HRAS—stomach cancer	9.26e-05	0.00312	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGG—stomach cancer	9.03e-05	0.00305	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADRB2—stomach cancer	8.92e-05	0.00301	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—MAPK1—stomach cancer	8.83e-05	0.00298	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PPP2R1A—stomach cancer	8.74e-05	0.00295	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKAA1—stomach cancer	8.7e-05	0.00294	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RBP4—stomach cancer	8.4e-05	0.00284	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL8—stomach cancer	8.39e-05	0.00283	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—stomach cancer	8.37e-05	0.00283	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—HRAS—stomach cancer	8.34e-05	0.00282	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HSPB1—stomach cancer	7.22e-05	0.00244	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGTR2—stomach cancer	7.22e-05	0.00244	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BMP2—stomach cancer	7.14e-05	0.00241	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—F2R—stomach cancer	7.14e-05	0.00241	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—HRAS—stomach cancer	7.09e-05	0.00239	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKR1C3—stomach cancer	7.03e-05	0.00237	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HTR1A—stomach cancer	6.95e-05	0.00235	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCB—stomach cancer	6.73e-05	0.00227	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ANXA1—stomach cancer	6.71e-05	0.00227	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRB1—stomach cancer	6.5e-05	0.0022	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RPS6—stomach cancer	6.21e-05	0.0021	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCB—stomach cancer	6.11e-05	0.00206	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6ST—stomach cancer	6.09e-05	0.00206	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HBEGF—stomach cancer	5.71e-05	0.00193	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6R—stomach cancer	5.43e-05	0.00183	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RHOA—stomach cancer	5.4e-05	0.00182	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ADRB2—stomach cancer	5.27e-05	0.00178	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PPP2R1A—stomach cancer	5.16e-05	0.00174	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RHOA—stomach cancer	4.91e-05	0.00166	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SMAD4—stomach cancer	4.79e-05	0.00162	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL8—stomach cancer	4.74e-05	0.0016	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FYN—stomach cancer	4.55e-05	0.00154	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL8—stomach cancer	4.31e-05	0.00145	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGFR2—stomach cancer	4.27e-05	0.00144	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IRS2—stomach cancer	3.91e-05	0.00132	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CAV1—stomach cancer	3.79e-05	0.00128	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOA1—stomach cancer	3.79e-05	0.00128	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKCB—stomach cancer	3.61e-05	0.00122	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6ST—stomach cancer	3.6e-05	0.00121	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APC—stomach cancer	3.46e-05	0.00117	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK3—stomach cancer	3.31e-05	0.00112	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6R—stomach cancer	3.21e-05	0.00108	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK1—stomach cancer	3.15e-05	0.00106	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EGFR—stomach cancer	3.15e-05	0.00106	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CA—stomach cancer	3.01e-05	0.00102	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SERPINE1—stomach cancer	3e-05	0.00101	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KRAS—stomach cancer	2.97e-05	0.001	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RHOA—stomach cancer	2.9e-05	0.000978	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOS3—stomach cancer	2.87e-05	0.000968	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CA—stomach cancer	2.73e-05	0.000922	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB2—stomach cancer	2.68e-05	0.000906	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL8—stomach cancer	2.54e-05	0.000859	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRAS—stomach cancer	2.53e-05	0.000853	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN1B—stomach cancer	2.49e-05	0.000839	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—stomach cancer	2.42e-05	0.000817	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCND1—stomach cancer	2.37e-05	0.0008	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JUN—stomach cancer	2.37e-05	0.000799	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—stomach cancer	2.3e-05	0.000777	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN1A—stomach cancer	2.29e-05	0.000774	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK8—stomach cancer	2.24e-05	0.000756	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—stomach cancer	2.07e-05	0.000698	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—stomach cancer	2.05e-05	0.000691	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK3—stomach cancer	1.96e-05	0.00066	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYC—stomach cancer	1.9e-05	0.000642	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK1—stomach cancer	1.86e-05	0.000628	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGFR—stomach cancer	1.86e-05	0.000628	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KRAS—stomach cancer	1.76e-05	0.000593	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CA—stomach cancer	1.61e-05	0.000545	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TP53—stomach cancer	1.56e-05	0.000527	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRAS—stomach cancer	1.49e-05	0.000504	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—stomach cancer	1.43e-05	0.000483	CbGpPWpGaD
